APO Research
Talk to an analyst

APO RESEARCH · REPORT

Filgrastim Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Filgrastim Injection Market Outlook and Growth Opportunities 2026

2 January 2026191 pages

Choose your research edition.

Industry ResearchFilgrastim Injection Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Filgrastim Injection Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Filgrastim Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Filgrastim Injection Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Filgrastim Injection Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Filgrastim Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Filgrastim Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Filgrastim Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Filgrastim Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Filgrastim Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Filgrastim Injection market include Teva Pharmaceuticals, Novartis AG, Pfizer, Amgen Inc and Accord Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Filgrastim Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Filgrastim Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Filgrastim Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Filgrastim Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Filgrastim Injection Segment by Company

Teva Pharmaceuticals

Novartis AG

Pfizer

Amgen Inc

Accord Healthcare

Filgrastim Injection Segment by Type

300mcg/0.5mL (Prefilled Syringe)

300mcg/mL (vial)

480mcg/0.8mL (Prefilled Syringe)

480mcg/1.6 mL (vial)

Filgrastim Injection Segment by Application

Adult Use

Pediatric Use

Geriatric Use

Filgrastim Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Filgrastim Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Filgrastim Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Filgrastim Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Filgrastim Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Filgrastim Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Filgrastim Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Filgrastim Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Filgrastim Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Filgrastim Injection industry.

Chapter 3: Detailed analysis of Filgrastim Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Filgrastim Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Filgrastim Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Filgrastim Injection Industry Trends Table 2. Filgrastim Injection Industry Drivers Table 3. Filgrastim Injection Industry Opportunities and Challenges Table 4. Filgrastim Injection Industry Restraints Table 5. Global Filgrastim Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Filgrastim Injection Revenue Share by Company (2021-2026) Table 7. Global Filgrastim Injection Sales Volume by Company (K L) & (2021-2026) Table 8. Global Filgrastim Injection Sales Volume Share by Company (2021-2026) Table 9. Global Filgrastim Injection Average Price (US$/L) of Company (2021-2026) Table 10. Global Filgrastim Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Filgrastim Injection Key Company Manufacturing Base & Headquarters Table 12. Global Filgrastim Injection Company, Product Type & Application Table 13. Global Filgrastim Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Filgrastim Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 300mcg/0.5mL (Prefilled Syringe) Table 18. Significant Companies of 300mcg/mL (vial) Table 19. Significant Companies of 480mcg/0.8mL (Prefilled Syringe) Table 20. Significant Companies of 480mcg/1.6 mL (vial) Table 21. Global Filgrastim Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K L) Table 22. Global Filgrastim Injection Sales Volume by Type (2021-2026) & (K L) Table 23. Global Filgrastim Injection Sales Volume by Type (2027-2032) & (K L) Table 24. Global Filgrastim Injection Sales Volume Share by Type (2021-2026) Table 25. Global Filgrastim Injection Sales Volume Share by Type (2027-2032) Table 26. Global Filgrastim Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Filgrastim Injection Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Filgrastim Injection Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Filgrastim Injection Sales Value Share by Type (2021-2026) Table 30. Global Filgrastim Injection Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Adult Use Table 32. Significant Companies of Pediatric Use Table 33. Significant Companies of Geriatric Use Table 34. Global Filgrastim Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K L) Table 35. Global Filgrastim Injection Sales Volume by Application (2021-2026) & (K L) Table 36. Global Filgrastim Injection Sales Volume by Application (2027-2032) & (K L) Table 37. Global Filgrastim Injection Sales Volume Share by Application (2021-2026) Table 38. Global Filgrastim Injection Sales Volume Share by Application (2027-2032) Table 39. Global Filgrastim Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Filgrastim Injection Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Filgrastim Injection Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Filgrastim Injection Sales Value Share by Application (2021-2026) Table 43. Global Filgrastim Injection Sales Value Share by Application (2027-2032) Table 44. Global Filgrastim Injection Sales by Region: 2021 VS 2025 VS 2032 (K L) Table 45. Global Filgrastim Injection Sales by Region (2021-2026) & (K L) Table 46. Global Filgrastim Injection Sales Market Share by Region (2021-2026) Table 47. Global Filgrastim Injection Sales by Region (2027-2032) & (K L) Table 48. Global Filgrastim Injection Sales Market Share by Region (2027-2032) Table 49. Global Filgrastim Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Filgrastim Injection Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Filgrastim Injection Sales Value Share by Region (2021-2026) Table 52. Global Filgrastim Injection Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Filgrastim Injection Sales Value Share by Region (2027-2032) Table 54. Global Filgrastim Injection Market Average Price (US$/L) by Region (2021-2026) Table 55. Global Filgrastim Injection Market Average Price (US$/L) by Region (2027-2032) Table 56. Global Filgrastim Injection Sales by Country: 2021 VS 2025 VS 2032 (K L) Table 57. Global Filgrastim Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Filgrastim Injection Sales by Country (2021-2026) & (K L) Table 59. Global Filgrastim Injection Sales Market Share by Country (2021-2026) Table 60. Global Filgrastim Injection Sales by Country (2027-2032) & (K L) Table 61. Global Filgrastim Injection Sales Market Share by Country (2027-2032) Table 62. Global Filgrastim Injection Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Filgrastim Injection Sales Value Market Share by Country (2021-2026) Table 64. Global Filgrastim Injection Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Filgrastim Injection Sales Value Market Share by Country (2027-2032) Table 66. Teva Pharmaceuticals Company Information Table 67. Teva Pharmaceuticals Business Overview Table 68. Teva Pharmaceuticals Filgrastim Injection Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 69. Teva Pharmaceuticals Filgrastim Injection Product Portfolio Table 70. Teva Pharmaceuticals Recent Development Table 71. Novartis AG Company Information Table 72. Novartis AG Business Overview Table 73. Novartis AG Filgrastim Injection Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 74. Novartis AG Filgrastim Injection Product Portfolio Table 75. Novartis AG Recent Development Table 76. Pfizer Company Information Table 77. Pfizer Business Overview Table 78. Pfizer Filgrastim Injection Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 79. Pfizer Filgrastim Injection Product Portfolio Table 80. Pfizer Recent Development Table 81. Amgen Inc Company Information Table 82. Amgen Inc Business Overview Table 83. Amgen Inc Filgrastim Injection Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 84. Amgen Inc Filgrastim Injection Product Portfolio Table 85. Amgen Inc Recent Development Table 86. Accord Healthcare Company Information Table 87. Accord Healthcare Business Overview Table 88. Accord Healthcare Filgrastim Injection Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 89. Accord Healthcare Filgrastim Injection Product Portfolio Table 90. Accord Healthcare Recent Development Table 91. Key Raw Materials Table 92. Raw Materials Key Suppliers Table 93. Filgrastim Injection Distributors List Table 94. Filgrastim Injection Customers List Table 95. Research Programs/Design for This Report Table 96. Authors List of This Report Table 97. Secondary Sources Table 98. Primary Sources List of Figures Figure 1. Filgrastim Injection Product Image Figure 2. Global Filgrastim Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Filgrastim Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Filgrastim Injection Sales (2021-2032) & (K L) Figure 5. Global Filgrastim Injection Sales Average Price (US$/L) & (2021-2032) Figure 6. Global Filgrastim Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 300mcg/0.5mL (Prefilled Syringe) Image Figure 10. 300mcg/mL (vial) Image Figure 11. 480mcg/0.8mL (Prefilled Syringe) Image Figure 12. 480mcg/1.6 mL (vial) Image Figure 13. Global Filgrastim Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K L) Figure 14. Global Filgrastim Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Filgrastim Injection Sales Volume Share by Type (2021-2032) Figure 16. Global Filgrastim Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Filgrastim Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Filgrastim Injection Sales Value Share by Type (2021-2032) Figure 19. Adult Use Image Figure 20. Pediatric Use Image Figure 21. Geriatric Use Image Figure 22. Global Filgrastim Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K L) Figure 23. Global Filgrastim Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Filgrastim Injection Sales Volume Share by Application (2021-2032) Figure 25. Global Filgrastim Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Filgrastim Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Filgrastim Injection Sales Value Share by Application (2021-2032) Figure 28. Global Filgrastim Injection Sales by Region: 2021 VS 2025 VS 2032 (K L) Figure 29. Global Filgrastim Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Filgrastim Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Filgrastim Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Filgrastim Injection Sales Value (2021-2032) & (US$ Million) Figure 33. North America Filgrastim Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Filgrastim Injection Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Filgrastim Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Filgrastim Injection Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Filgrastim Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Filgrastim Injection Sales Value (2021-2032) & (US$ Million) Figure 39. South America Filgrastim Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Filgrastim Injection Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Filgrastim Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Filgrastim Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Filgrastim Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Filgrastim Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Filgrastim Injection Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Filgrastim Injection Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • 300mcg/0.5mL (Prefilled Syringe)
  • 300mcg/mL (vial)
  • 480mcg/0.8mL (Prefilled Syringe)
  • 480mcg/1.6 mL (vial)
Applications
  • Adult Use
  • Pediatric Use
  • Geriatric Use
Companies covered
  • Teva Pharmaceuticals
  • Novartis AG
  • Pfizer
  • Amgen Inc
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Filgrastim Injection Sales Value (2021-2032)
  4. 1.2.2 Global Filgrastim Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Filgrastim Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Filgrastim Injection Market Dynamics
  1. 2.1 Filgrastim Injection Industry Trends
  2. 2.2 Filgrastim Injection Industry Drivers
  3. 2.3 Filgrastim Injection Industry Opportunities and Challenges
  4. 2.4 Filgrastim Injection Industry Restraints
3 Filgrastim Injection Market by Company
  1. 3.1 Global Filgrastim Injection Company Revenue Ranking in 2025
  2. 3.2 Global Filgrastim Injection Revenue by Company (2021-2026)
  3. 3.3 Global Filgrastim Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Filgrastim Injection Average Price by Company (2021-2026)
  5. 3.5 Global Filgrastim Injection Company Ranking (2024-2026)
  6. 3.6 Global Filgrastim Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Filgrastim Injection Company Product Type and Application
  8. 3.8 Global Filgrastim Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Filgrastim Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Filgrastim Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Filgrastim Injection Market by Type
  1. 4.1 Filgrastim Injection Type Introduction
  2. 4.1.1 300mcg/0.5mL (Prefilled Syringe)
  3. 4.1.2 300mcg/mL (vial)
  4. 4.1.3 480mcg/0.8mL (Prefilled Syringe)
  5. 4.1.4 480mcg/1.6 mL (vial)
  6. 4.2 Global Filgrastim Injection Sales Volume by Type
  7. 4.2.1 Global Filgrastim Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Filgrastim Injection Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Filgrastim Injection Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Filgrastim Injection Sales Value by Type
  11. 4.3.1 Global Filgrastim Injection Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Filgrastim Injection Sales Value by Type (2021-2032)
  13. 4.3.3 Global Filgrastim Injection Sales Value Share by Type (2021-2032)
5 Filgrastim Injection Market by Application
  1. 5.1 Filgrastim Injection Application Introduction
  2. 5.1.1 Adult Use
  3. 5.1.2 Pediatric Use
  4. 5.1.3 Geriatric Use
  5. 5.2 Global Filgrastim Injection Sales Volume by Application
  6. 5.2.1 Global Filgrastim Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Filgrastim Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Filgrastim Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Filgrastim Injection Sales Value by Application
  10. 5.3.1 Global Filgrastim Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Filgrastim Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Filgrastim Injection Sales Value Share by Application (2021-2032)
6 Filgrastim Injection Regional Sales and Value Analysis
  1. 6.1 Global Filgrastim Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Filgrastim Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Filgrastim Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Filgrastim Injection Sales by Region (2027-2032)
  5. 6.3 Global Filgrastim Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Filgrastim Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Filgrastim Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Filgrastim Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Filgrastim Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Filgrastim Injection Sales Value (2021-2032)
  12. 6.6.2 North America Filgrastim Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Filgrastim Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Filgrastim Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Filgrastim Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Filgrastim Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Filgrastim Injection Sales Value (2021-2032)
  21. 6.9.2 South America Filgrastim Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Filgrastim Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Filgrastim Injection Sales Value Share by Country, 2025 VS 2032
7 Filgrastim Injection Country-level Sales and Value Analysis
  1. 7.1 Global Filgrastim Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Filgrastim Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Filgrastim Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Filgrastim Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Filgrastim Injection Sales by Country (2027-2032)
  6. 7.4 Global Filgrastim Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Filgrastim Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Filgrastim Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Filgrastim Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Filgrastim Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Filgrastim Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Filgrastim Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Filgrastim Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Filgrastim Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Filgrastim Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Filgrastim Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Filgrastim Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Filgrastim Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Filgrastim Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Filgrastim Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Filgrastim Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Filgrastim Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Filgrastim Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Filgrastim Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Filgrastim Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Filgrastim Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Filgrastim Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Filgrastim Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Filgrastim Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Filgrastim Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Filgrastim Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Filgrastim Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Filgrastim Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Filgrastim Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Filgrastim Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Filgrastim Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Filgrastim Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Filgrastim Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceuticals
  2. 8.1.1 Teva Pharmaceuticals Company Information
  3. 8.1.2 Teva Pharmaceuticals Business Overview
  4. 8.1.3 Teva Pharmaceuticals Filgrastim Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceuticals Filgrastim Injection Product Portfolio
  6. 8.1.5 Teva Pharmaceuticals Recent Developments
  7. 8.2 Novartis AG
  8. 8.2.1 Novartis AG Company Information
  9. 8.2.2 Novartis AG Business Overview
  10. 8.2.3 Novartis AG Filgrastim Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novartis AG Filgrastim Injection Product Portfolio
  12. 8.2.5 Novartis AG Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Filgrastim Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Filgrastim Injection Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Amgen Inc
  20. 8.4.1 Amgen Inc Company Information
  21. 8.4.2 Amgen Inc Business Overview
  22. 8.4.3 Amgen Inc Filgrastim Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Amgen Inc Filgrastim Injection Product Portfolio
  24. 8.4.5 Amgen Inc Recent Developments
  25. 8.5 Accord Healthcare
  26. 8.5.1 Accord Healthcare Company Information
  27. 8.5.2 Accord Healthcare Business Overview
  28. 8.5.3 Accord Healthcare Filgrastim Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Accord Healthcare Filgrastim Injection Product Portfolio
  30. 8.5.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Filgrastim Injection Value Chain Analysis
  2. 9.1.1 Filgrastim Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Filgrastim Injection Sales Mode & Process
  6. 9.2 Filgrastim Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Filgrastim Injection Distributors
  9. 9.2.3 Filgrastim Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst